BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choi D, Lim HK, Rhim H, Kim YS, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Yoo BC. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17:684-692. [PMID: 17093964 DOI: 10.1007/s00330-006-0461-5] [Cited by in Crossref: 229] [Cited by in F6Publishing: 218] [Article Influence: 14.3] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Li W. Recent update on comprehensive therapy for advanced hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(8): 845-855 [PMID: 34457190 DOI: 10.4251/wjgo.v13.i8.845] [Reference Citation Analysis]
2 Lencioni R, Crocetti L, Petruzzi P, Vignali C, Bozzi E, Della Pina C, Bargellini I, Cioni D, Oliveri F, De Simone P, Bartolozzi C, Brunetto M, Filipponi F. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: A pilot clinical study. Journal of Hepatology 2008;49:217-22. [DOI: 10.1016/j.jhep.2008.03.021] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 5.3] [Reference Citation Analysis]
3 Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, Ensminger WD, Gibbs JF, Laheru D, Malafa MP, Marrero J, Meranze SG, Mulvihill SJ, Park JO, Posey JA, Sachdev J, Salem R, Sigurdson ER, Sofocleous C, Vauthey JN, Venook AP, Goff LW, Yen Y, Zhu AX. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw. 2009;7:350-391. [PMID: 19406039 DOI: 10.6004/jnccn.2009.0027] [Cited by in Crossref: 299] [Cited by in F6Publishing: 324] [Article Influence: 23.0] [Reference Citation Analysis]
4 Woo S, Lee JM, Yoon JH, Joo I, Kim SH, Lee JY, Yoon JH, Kim YJ, Han JK, Choi BI. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results. Radiology. 2013;268:589-600. [PMID: 23513241 DOI: 10.1148/radiol.13121736] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 4.6] [Reference Citation Analysis]
5 Yun BL, Lee JM, Baek JH, Kim SH, Lee JY, Han JK, Choi BI. Radiofrequency ablation for treating liver metastases from a non-colorectal origin. Korean J Radiol 2011;12:579-87. [PMID: 21927559 DOI: 10.3348/kjr.2011.12.5.579] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
6 Moribata K, Tamai H, Shingaki N, Mori Y, Shiraki T, Enomoto S, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Ichinose M. Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation. World J Hepatol 2012;4:374-81. [PMID: 23355915 DOI: 10.4254/wjg.v4.i12.374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
7 Di Vece F, Tombesi P, Ermili F, Maraldi C, Sartori S. Coagulation Areas Produced by Cool-Tip Radiofrequency Ablation and Microwave Ablation Using a Device to Decrease Back-Heating Effects: A Prospective Pilot Study. Cardiovasc Intervent Radiol. [DOI: 10.1007/s00270-013-0733-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
8 Galanakis N, Kehagias E, Matthaiou N, Samonakis D, Tsetis D. Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review. Hepat Oncol 2018;5:HEP07. [PMID: 31293775 DOI: 10.2217/hep-2018-0001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Kim YS, Lee WJ, Rhim H, Lim HK, Choi D, Lee JY. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol. 2010;195:758-765. [PMID: 20729457 DOI: 10.2214/ajr.09.2954] [Cited by in Crossref: 166] [Cited by in F6Publishing: 76] [Article Influence: 13.8] [Reference Citation Analysis]
10 Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma. Korean J Intern Med. 2016;31:242-252. [PMID: 26874512 DOI: 10.3904/kjim.2015.112] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
11 Cheng Z, Xiao Q, Wang Y, Sun Y, Lu T, Liang P. 915MHz microwave ablation with implanted internal cooled-shaft antenna: initial experimental study in in vivo porcine livers. Eur J Radiol. 2011;79:131-135. [PMID: 20074887 DOI: 10.1016/j.ejrad.2009.12.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
12 Kao WY, Su CW, Chiou YY, Chiu NC, Liu CA, Fang KC, Huo TI, Huang YH, Chang CC, Hou MC, Lin HC, Wu JC. Hepatocellular Carcinoma: Nomograms Based on the Albumin-Bilirubin Grade to Assess the Outcomes of Radiofrequency Ablation. Radiology. 2017;285:670-680. [PMID: 28562211 DOI: 10.1148/radiol.2017162382] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 8.2] [Reference Citation Analysis]
13 Rhim H, Lim HK. Radiofrequency ablation of hepatocellular carcinoma: pros and cons. Gut Liver 2010;4 Suppl 1:S113-8. [PMID: 21103289 DOI: 10.5009/gnl.2010.4.S1.S113] [Cited by in Crossref: 37] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
14 Lencioni R. Loco-regional treatment of hepatocellular carcinoma. Hepatology 2010;52:762-73. [DOI: 10.1002/hep.23725] [Cited by in Crossref: 323] [Cited by in F6Publishing: 320] [Article Influence: 26.9] [Reference Citation Analysis]
15 Bertrand J, Caillol F, Borentain P, Raoul JL, Heyries L, Bories E, Pesenti C, Ratone JP, Bernard JP, Gerolami R, Giovannini M. Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients. Hepat Med 2015;7:21-7. [PMID: 26056497 DOI: 10.2147/HMER.S67940] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Ke S, Ding XM, Qian XJ, Zhou YM, Cao BX, Gao K, Sun WB. Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: is ablative margin of more than 1 cm justified? World J Gastroenterol 2013;19:7389-98. [PMID: 24259969 DOI: 10.3748/wjg.v19.i42.7389] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
17 Park BK, Kim CK, Lee HM. Image-guided radiofrequency ablation of Bosniak category III or IV cystic renal tumors: initial clinical experience. Eur Radiol 2008;18:1519-25. [DOI: 10.1007/s00330-008-0891-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
18 Yan K, Chen MH, Yang W, Wang YB, Gao W, Hao CY, Xing BC, Huang XF. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol. 2008;67:336-347. [PMID: 17765421 DOI: 10.1016/j.ejrad.2007.07.007] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 5.0] [Reference Citation Analysis]
19 Yang W, Yan K, Chen M, Wu J, Zhang Z, Lee J, Wang S, Wu W. Preliminary experience with direct percutaneous arterial embolisation combined with radiofrequency ablation for hypervascular HCC. International Journal of Hyperthermia 2017. [DOI: 10.1080/02656736.2017.1305126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
20 Watanabe H, Kanematsu M, Goshima S, Yoshida M, Kawada H, Kondo H, Moriyama N. Is gadoxetate disodium-enhanced MRI useful for detecting local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy? AJR Am J Roentgenol. 2012;198:589-595. [PMID: 22357997 DOI: 10.2214/ajr.11.6844] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
21 Tamura Y, Igarashi M, Suda T, Wakai T, Shirai Y, Umemura T, Tanaka E, Kakizaki S, Takagi H, Hiasa Y, Onji M, Aoyagi Y. Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative Treatment. Dig Dis Sci 2010;55:2095-101. [DOI: 10.1007/s10620-009-0954-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
22 Kairaluoma V, Karjalainen M, Pohjanen VM, Saarnio J, Niemelä J, Huhta H, Helminen O. Treatment trends and outcomes of hepatocellular carcinoma in a single center for 35 years. Minerva Surg 2021;76:252-63. [PMID: 33890436 DOI: 10.23736/S2724-5691.21.08426-1] [Reference Citation Analysis]
23 Hirooka M, Ochi H, Koizumi Y, Tokumoto Y, Hiraoka A, Kumagi T, Abe M, Tanaka H, Hiasa Y. Local recurrence of hepatocellular carcinoma in the tumor blood drainage area following radiofrequency ablation. Mol Clin Oncol 2014;2:182-6. [PMID: 24649330 DOI: 10.3892/mco.2013.229] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
24 Rhim H, Choi D, Kim YS, Lim HK, Choe BK. Ultrasonography-guided percutaneous radiofrequency ablation of hepatocellular carcinomas: a feasibility scoring system for planning sonography. Eur J Radiol. 2010;75:253-258. [PMID: 19427152 DOI: 10.1016/j.ejrad.2009.04.014] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
25 Desiderio J, Trastulli S, Pasquale R, Cavaliere D, Cirocchi R, Boselli C, Noya G, Parisi A. Could radiofrequency ablation replace liver resection for small hepatocellular carcinoma in patients with compensated cirrhosis? A 5-year follow-up. Langenbecks Arch Surg 2013;398:55-62. [PMID: 23224564 DOI: 10.1007/s00423-012-1029-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
26 Kim H, Rhim H, Choi D, Lim HK, Kim YS, Lee WJ, Joh JW. Recurrence and treatment pattern in long-term survivors with hepatocellular carcinoma: a comparison between radiofrequency ablation and surgery as a first-line treatment. World J Surg. 2010;34:1881-1886. [PMID: 20376449 DOI: 10.1007/s00268-010-0533-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
27 Park Y, Choi D, Lim HK, Rhim H, Kim Y, Kim SH, Lee WJ. Growth Rate of New Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation: Evaluation with Multiphase CT. American Journal of Roentgenology 2008;191:215-20. [DOI: 10.2214/ajr.07.3297] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
28 Park HJ, Lee MW, Rhim H, Cha DI, Kang TW, Lim S, Song KD, Lim HK. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography. Clin Radiol. 2015;70:387-394. [PMID: 25582889 DOI: 10.1016/j.crad.2014.12.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
29 Tsuchiya K, Komuta M, Yasui Y, Tamaki N, Hosokawa T, Ueda K, Kuzuya T, Itakura J, Nakanishi H, Takahashi Y, Kurosaki M, Asahina Y, Enomoto N, Sakamoto M, Izumi N. Expression of Keratin 19 Is Related to High Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation. Oncology 2011;80:278-88. [DOI: 10.1159/000328448] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 4.1] [Reference Citation Analysis]
30 Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology. 2012;262:43-58. [PMID: 22190656 DOI: 10.1148/radiol.11110144] [Cited by in Crossref: 211] [Cited by in F6Publishing: 202] [Article Influence: 21.1] [Reference Citation Analysis]
31 Han K, Kim JH. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system. World J Gastroenterol 2015; 21(36): 10327-10335 [PMID: 26420959 DOI: 10.3748/wjg.v21.i36.10327] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 50] [Article Influence: 7.7] [Reference Citation Analysis]
32 Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg. 2009;249:20-25. [PMID: 19106671 DOI: 10.1097/sla.0b013e31818eec29] [Cited by in Crossref: 216] [Cited by in F6Publishing: 86] [Article Influence: 16.6] [Reference Citation Analysis]
33 Kalra N, Gupta P, Chawla Y, Khandelwal N. Locoregional treatment for hepatocellular carcinoma: The best is yet to come. World J Radiol 2015; 7(10): 306-318 [PMID: 26516427 DOI: 10.4329/wjr.v7.i10.306] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
34 Kim YJ, Lee MW, Park HS. Small hepatocellular carcinomas: ultrasonography guided percutaneous radiofrequency ablation. Abdom Imaging 2013;38:98-111. [DOI: 10.1007/s00261-012-9883-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
35 N'kontchou G, Mahamoudi A, Aout M, Ganne-carrié N, Grando V, Coderc E, Vicaut E, Trinchet JC, Sellier N, Beaugrand M, Seror O. Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009;50:1475-83. [DOI: 10.1002/hep.23181] [Cited by in Crossref: 284] [Cited by in F6Publishing: 268] [Article Influence: 21.8] [Reference Citation Analysis]
36 Hasegawa K, Makuuchi M, Kudo M, Okazaki M. Hepatectomy versus radiofrequency ablation for early hepatocellular carcinoma: Reply. Journal of Hepatology 2009;50:1052-3. [DOI: 10.1016/j.jhep.2009.02.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Wang XL, Li K, Su ZZ, Huang ZP, Wang P, Zheng RQ. Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma. World J Gastroenterol 2015; 21(17): 5345-5351 [PMID: 25954109 DOI: 10.3748/wjg.v21.i17.5345] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
38 Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, Asaoka Y, Sato T, Masuzaki R, Kondo Y, Goto T, Yoshida H, Omata M, Koike K. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2012;107:569-77; quiz 578. [PMID: 22158026 DOI: 10.1038/ajg.2011.425] [Cited by in Crossref: 406] [Cited by in F6Publishing: 385] [Article Influence: 36.9] [Reference Citation Analysis]
39 Lencioni R, Crocetti L. Image-guided thermal ablation of hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2008;66:200-7. [DOI: 10.1016/j.critrevonc.2008.01.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
40 Chen M, Wu W, Yang W, Dai Y, Gao W, Yin S, Yan K. The Use of Contrast-Enhanced Ultrasonography in the Selection of Patients With Hepatocellular Carcinoma for Radio Frequency Ablation Therapy. Journal of Ultrasound in Medicine 2007;26:1055-63. [DOI: 10.7863/jum.2007.26.8.1055] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
41 Kei SK, Rhim H, Choi D, Lee WJ, Lim HK, Kim YS. Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. AJR Am J Roentgenol. 2008;190:1544-1551. [PMID: 18492905 DOI: 10.2214/ajr.07.2798] [Cited by in Crossref: 65] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
42 Kawamura R, Seki T, Umehara H, Ikeda K, Inokuchi R, Asayama T, Yamaguchi T, Takahashi Y, Sakao M, Lencioni R. Combined treatment of large hepatocellular carcinoma with transcatheter arterial chemoembolization and percutaneous ethanol injection with a multipronged needle: experimental and clinical investigation. Cardiovasc Intervent Radiol. 2012;35:325-333. [PMID: 21607824 DOI: 10.1007/s00270-011-0184-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
43 Calandri M, Mauri G, Yevich S, Gazzera C, Basile D, Gatti M, Veltri A, Fonio P. Fusion Imaging and Virtual Navigation to Guide Percutaneous Thermal Ablation of Hepatocellular Carcinoma: A Review of the Literature. Cardiovasc Intervent Radiol 2019;42:639-47. [DOI: 10.1007/s00270-019-02167-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
44 Kovács A, Iezzi R, Cellini F, Lancellotta V, Bischoff P, Carchesio F, Tagliaferri L, Kovács G, Gambacorta MA. Critical review of multidisciplinary non-surgical local interventional ablation techniques in primary or secondary liver malignancies. J Contemp Brachytherapy 2019;11:589-600. [PMID: 31969919 DOI: 10.5114/jcb.2019.90466] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
45 Shao GL, Zheng JP, Guo LW, Chen YT, Zeng H, Yao Z. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study. Medicine (Baltimore) 2017;96:e5518. [PMID: 28099329 DOI: 10.1097/MD.0000000000005518] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Kim YS, Rhim H, Lim HK. Imaging after radiofrequency ablation of hepatic tumors. Semin Ultrasound CT MR. 2009;30:49-66. [PMID: 19358437 DOI: 10.1053/j.sult.2008.12.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
47 Crocetti L, de Baere T, Lencioni R. Quality improvement guidelines for radiofrequency ablation of liver tumours. Cardiovasc Intervent Radiol. 2010;33:11-17. [PMID: 19924474 DOI: 10.1007/s00270-009-9736-y] [Cited by in Crossref: 165] [Cited by in F6Publishing: 157] [Article Influence: 13.8] [Reference Citation Analysis]
48 Kim JE, Kim YS, Rhim H, Lim HK, Lee MW, Choi D, Shin SW, Cho SK. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance. Eur J Radiol. 2011;79:e80-e84. [PMID: 21514757 DOI: 10.1016/j.ejrad.2011.03.090] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 4.9] [Reference Citation Analysis]
49 Bartolotta TV, Taibbi A, Matranga D, Sandonato L, Asta S, Midiri M, Lagalla R. Incidence of new foci of hepatocellular carcinoma after radiofrequency ablation: role of multidetector CT. Radiol Med 2012;117:739-48. [PMID: 22095421 DOI: 10.1007/s11547-011-0752-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
50 Lee MW, Rhim H, Cha DI, Kim YJ, Choi D, Kim YS, Lim HK. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography. AJR Am J Roentgenol. 2012;198:1438-1444. [PMID: 22623560 DOI: 10.2214/ajr.11.7568] [Cited by in Crossref: 76] [Cited by in F6Publishing: 35] [Article Influence: 7.6] [Reference Citation Analysis]
51 Wei Y, Dai F, Yi Y, Ye W, Zhao W. Impact of local tumor lesion treatments and preoperative indicators on the survival of patients with small hepatocellular carcinomas. Oncol Lett 2018;16:5050-8. [PMID: 30250572 DOI: 10.3892/ol.2018.9263] [Reference Citation Analysis]
52 Shiraishi R, Yamasaki T, Saeki I, Okita K, Yamaguchi Y, Uchida K, Terai S, Sakaida I. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma. Am J Clin Oncol. 2008;31:311-316. [PMID: 18845987 DOI: 10.1097/coc.0b013e31815e4539] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
53 Park BJ, Byun JH, Jin YH, Won HJ, Shin YM, Kim KW, Park SJ, Kim PN. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety. J Vasc Interv Radiol. 2009;20:490-499. [PMID: 19328427 DOI: 10.1016/j.jvir.2009.01.004] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
54 Yang JD, Harmsen WS, Slettedahl SW, Chaiteerakij R, Enders FT, Therneau TM, Orsini L, Kim WR, Roberts LR. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. Clin Gastroenterol Hepatol. 2011;9:617-623.e1. [PMID: 21459158 DOI: 10.1016/j.cgh.2011.03.027] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 7.1] [Reference Citation Analysis]
55 Qian LX, Wei HT, Hu XD. Current situation and progress of local ablation therapy for hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2008; 16(18): 1955-1961 [DOI: 10.11569/wcjd.v16.i18.1955] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Karabulut K, Aucejo F, Akyildiz HY, Siperstein A, Berber E. Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience. Surg Endosc. 2012;26:990-997. [PMID: 22038164 DOI: 10.1007/s00464-011-1983-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
57 Sandonato L, Cipolla C, Soresi M, Lo Re G, Latteri F, Lombardo G, Bova V, Latteri MA. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinoma: a case report. Cases J 2009;2:7987. [PMID: 19830036 DOI: 10.4076/1757-1626-2-7987] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 Zhang L, Ge N, Chen Y, Xie X, Yin X, Gan Y, Zhang B, Zhang J, Chen R, Wang Y, Ye S, Ren Z. Long-term outcomes and prognostic analysis of radiofrequency ablation for small hepatocellular carcinoma: 10-year follow-up in Chinese patients. Med Oncol 2015;32. [DOI: 10.1007/s12032-015-0532-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
59 Kim JW, Kim JH, Sung KB, Ko HK, Shin JH, Kim PN, Choi HK, Ko GY, Yoon HK, Chun SY. Transarterial chemoembolization vs. radiofrequency ablation for the treatment of single hepatocellular carcinoma 2 cm or smaller. Am J Gastroenterol. 2014;109:1234-1240. [PMID: 24935276 DOI: 10.1038/ajg.2014.152] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
60 Girotra M, Soota K, Dhaliwal AS, Abraham RR, Garcia-Saenz-de-Sicilia M, Tharian B. Utility of endoscopic ultrasound and endoscopy in diagnosis and management of hepatocellular carcinoma and its complications: What does endoscopic ultrasonography offer above and beyond conventional cross-sectional imaging? World J Gastrointest Endosc 2018; 10(2): 56-68 [PMID: 29467916 DOI: 10.4253/wjge.v10.i2.56] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
61 Park MJ, Kim YS, Rhim H, Lim HK, Lee MW, Choi D. A comparison of US-guided percutaneous radiofrequency ablation of medium-sized hepatocellular carcinoma with a cluster electrode or a single electrode with a multiple overlapping ablation technique. J Vasc Interv Radiol. 2011;22:771-779. [PMID: 21616430 DOI: 10.1016/j.jvir.2011.02.005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
62 van der Sluis FJF, Bosch JL, Terkivatan T, de Man RA, Ijzermans JNM, Hunink MGM. Hepatocellular Adenoma: Cost-effectiveness of Different Treatment Strategies. Radiology 2009;252:737-46. [DOI: 10.1148/radiol.2523082219] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
63 Foltz G. Image-guided percutaneous ablation of hepatic malignancies. Semin Intervent Radiol. 2014;31:180-186. [PMID: 25071304 DOI: 10.1055/s-0034-1373792] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
64 Kim TW, Chung MK, Youm HY, Jeong JI, Son YI, Jeong HS, Baek CH. Bilateral neck metastases in upper aero-digestive tract cancer: emphasis on the distribution of lymphatic metastases and prognostic implications. J Surg Oncol 2012;105:553-8. [PMID: 22095558 DOI: 10.1002/jso.22145] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
65 Kim AY, Rhim H, Park M, Lee MW, Kim YS, Choi D, Lim HK. Venous thrombosis after radiofrequency ablation for hepatocellular carcinoma. AJR Am J Roentgenol. 2011;197:1474-1480. [PMID: 22109305 DOI: 10.2214/ajr.11.6495] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
66 Park Y, Kim YS, Rhim H, Lim HK, Choi D, Lee WJ. Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression. AJR Am J Roentgenol. 2009;193:757-763. [PMID: 19696290 DOI: 10.2214/ajr.08.2202] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
67 Yune Y, Kim S, Song I, Chun K. Comparative analysis of intraoperative radiofrequency ablation versus non-anatomical hepatic resection for small hepatocellular carcinoma: short-term result. Korean J Hepatobiliary Pancreat Surg 2015;19:173-80. [PMID: 26693237 DOI: 10.14701/kjhbps.2015.19.4.173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
68 Calandri M, Ruggeri V, Carucci P, Mirabella S, Veltri A, Fonio P, Gazzera C. Thermal ablation with fusion imaging guidance of hepatocellular carcinoma without conspicuity on conventional or contrast-enhanced US: surrounding anatomical landmarks matter. Radiol Med 2019;124:1043-8. [PMID: 31270723 DOI: 10.1007/s11547-019-01057-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
69 Rhim H. Recent advance of local ablation for hepatocellular carcinoma. J Korean Med Assoc 2013;56:964. [DOI: 10.5124/jkma.2013.56.11.964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Ryan MJ, Willatt J, Majdalany BS, Kielar AZ, Chong S, Ruma JA, Pandya A. Ablation techniques for primary and metastatic liver tumors. World J Hepatol 2016; 8(3): 191-199 [PMID: 26839642 DOI: 10.4254/wjh.v8.i3.191] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
71 Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella CM. Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablation. Acta Radiol. 2012;53:394-400. [PMID: 22393158 DOI: 10.1258/ar.2012.110471] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
72 Lee J, Lee JM, Yoon JH, Lee JY, Kim SH, Lee JE, Han JK, Choi BI. Percutaneous radiofrequency ablation with multiple electrodes for medium-sized hepatocellular carcinomas. Korean J Radiol 2012;13:34-43. [PMID: 22247634 DOI: 10.3348/kjr.2012.13.1.34] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
73 Choi D, Lim HK, Joh JW, Kim SJ, Kim MJ, Rhim H, Kim YS, Yoo BC, Paik SW, Park CK. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors. Ann Surg Oncol. 2007;14:3510-3518. [PMID: 17653800 DOI: 10.1245/s10434-007-9492-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
74 Kim S, Yoon CJ, Cho JY, Han HS, Yoon YS, Lee HW, Lee JS, Kim M, Lee B, Ahn S. Comparative long-term outcomes of laparoscopic hepatectomy and radiofrequency ablation for hepatocellular carcinoma located in the anterolateral segments of the liver. J Hepatobiliary Pancreat Sci 2021. [PMID: 34689415 DOI: 10.1002/jhbp.1064] [Reference Citation Analysis]
75 Fukumitsu N, Sugahara S, Nakayama H, Fukuda K, Mizumoto M, Abei M, Shoda J, Thono E, Tsuboi K, Tokuuye K. A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2009;74:831-836. [PMID: 19304408 DOI: 10.1016/j.ijrobp.2008.10.073] [Cited by in Crossref: 147] [Cited by in F6Publishing: 121] [Article Influence: 11.3] [Reference Citation Analysis]
76 Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol. 2011;21:2584-2596. [PMID: 21858539 DOI: 10.1007/s00330-011-2222-3] [Cited by in Crossref: 91] [Cited by in F6Publishing: 87] [Article Influence: 8.3] [Reference Citation Analysis]
77 Burgmans MC, Too CW, Fiocco M, Kerbert AJ, Lo RH, Schaapman JJ, van Erkel AR, Coenraad MJ, Tan BS. Differences in Patient Characteristics and Midterm Outcome Between Asian and European Patients Treated with Radiofrequency Ablation for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol 2016;39:1708-15. [PMID: 27671151 DOI: 10.1007/s00270-016-1462-7] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
78 Kobayashi M, Ikeda K, Kawamura Y, Yatsuji H, Hosaka T, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Saitoh S, Arase Y, Kumada H. High serum des-gamma-carboxy prothrombin level predicts poor prognosis after radiofrequency ablation of hepatocellular carcinoma. Cancer 2009;115:571-80. [PMID: 19117347 DOI: 10.1002/cncr.24031] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.5] [Reference Citation Analysis]
79 Cua IH, Lin CC, Lin CJ, Chen WT, Hsu CW, Chen YC, Wong SN, Lin SM. Treatment of hepatocellular carcinoma using internally cooled electrodes. A prospective comparison of modified automated vs. manual pulsed radiofrequency algorithms. Oncology 2007;72 Suppl 1:76-82. [PMID: 18087186 DOI: 10.1159/000111711] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
80 Yin X, Lu M. Percutaneous ablation for small hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2014;3:121-30. [DOI: 10.1586/egh.09.7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
81 Chu HH, Kim JH, Kim PN, Kim SY, Lim Y, Park SH, Ko H, Lee S. Surgical resection versus radiofrequency ablation very early‐stage HCC (≤2 cm Single HCC): A propensity score analysis. Liver Int 2019;39:2397-407. [DOI: 10.1111/liv.14258] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
82 Zhou Y, Ding J, Qin Z, Wang Y, Zhang J, Jia K, Wang Y, Zhou H, Wang F, Jing X. Predicting the survival rate of patients with hepatocellular carcinoma after thermal ablation by nomograms. Ann Transl Med 2020;8:1159. [PMID: 33241008 DOI: 10.21037/atm-20-6116] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 Park BK, Kim CK, Choi HY, Lee HM, Jeon SS, Seo SI, Han DH. Limitation for performing ultrasound-guided radiofrequency ablation of small renal masses. Eur J Radiol 2010;75:248-52. [PMID: 19394181 DOI: 10.1016/j.ejrad.2009.03.050] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
84 Del Pozo AC, López P. Management of hepatocellular carcinoma. Clin Liver Dis. 2007;11:305-321. [PMID: 17606209 DOI: 10.1016/j.cld.2007.04.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
85 Zhang W, Luo E, Gan J, Song X, Bao Z, Zhang H, Chen M. Long-term survival of hepatocellular carcinoma after percutaneous radiofrequency ablation guided by ultrasound. World J Surg Oncol 2017;15:122. [PMID: 28679433 DOI: 10.1186/s12957-017-1189-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
86 Francica G, Saviano A, De Sio I, De Matthaeis N, Brunello F, Cantamessa A, Giorgio A, Scognamiglio U, Fornari F, Giangregorio F, Piscaglia F, Gualandi S, Caturelli E, Roselli P, Rapaccini GL, Pompili M. Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients. Dig Liver Dis. 2013;45:336-341. [PMID: 23245589 DOI: 10.1016/j.dld.2012.10.022] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
87 Narsinh KH, Duncan DP, Newton IG, Minocha J, Rose SC. Liver-directed therapy for hepatocellular carcinoma. Abdom Radiol (NY). 2018;43:203-217. [PMID: 29230556 DOI: 10.1007/s00261-017-1435-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
88 Lencioni R, Crocetti L. Image-guided ablation for hepatocellular carcinoma. Recent Results Cancer Res. 2013;190:181-194. [PMID: 22941021 DOI: 10.1007/978-3-642-16037-0_12] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
89 Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A, Takahashi S, Toyota N, Ito K, Chayama K. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: Results and prognostic factors on long-term follow up: Percutaneous RFA for small HCC. Journal of Gastroenterology and Hepatology 2010;25:597-604. [DOI: 10.1111/j.1440-1746.2009.06125.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 5.1] [Reference Citation Analysis]
90 Kim YS, Lim HK, Rhim H, Lee MW. Ablation of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol. 2014;28:897-908. [PMID: 25260316 DOI: 10.1016/j.bpg.2014.08.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
91 Hermida M, Cassinotto C, Piron L, Assenat E, Pageaux GP, Escal L, Pierredon-Foulongne MA, Verzilli D, Jaber S, Guiu B. Percutaneous thermal ablation of hepatocellular carcinomas located in the hepatic dome using artificial carbon dioxide pneumothorax: retrospective evaluation of safety and efficacy. Int J Hyperthermia 2018;35:90-6. [PMID: 29923441 DOI: 10.1080/02656736.2018.1477206] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
92 Kuang M, Xie XY, Huang C, Wang Y, Lin MX, Xu ZF, Liu GJ, Lu MD. Long-term outcome of percutaneous ablation in very early-stage hepatocellular carcinoma. J Gastrointest Surg. 2011;15:2165-2171. [PMID: 21972056 DOI: 10.1007/s11605-011-1716-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.7] [Reference Citation Analysis]
93 Kim YS, Rhim H, Lim HK, Choi D, Lee WJ, Jeon TY, Joh JW, Kim SJ. Intraoperative radiofrequency ablation for hepatocellular carcinoma: long-term results in a large series. Ann Surg Oncol. 2008;15:1862-1870. [PMID: 18463926 DOI: 10.1245/s10434-008-9941-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
94 Ishii T, Numata K, Hao Y, Doba N, Hara K, Kondo M, Tanaka K, Maeda S. Evaluation of hepatocellular carcinoma tumor vascularity using contrast-enhanced ultrasonography as a predictor for local recurrence following radiofrequency ablation. Eur J Radiol 2017;89:234-41. [PMID: 28034569 DOI: 10.1016/j.ejrad.2016.12.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
95 Chu HH, Kim JH, Yoon HK, Ko HK, Gwon DI, Kim PN, Sung KB, Ko GY, Kim SY, Park SH. Chemoembolization Combined with Radiofrequency Ablation for Medium-Sized Hepatocellular Carcinoma: A Propensity-Score Analysis. J Vasc Interv Radiol. 2019;30:1533-1543. [PMID: 31471190 DOI: 10.1016/j.jvir.2019.06.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
96 Park MJ, Kim Y, Rhim H, Lim HK, Shin BS, Choi D, Lee MW, Kim DH. Prospective Analysis of the Pattern and Risk for Severe Vital Sign Changes During Percutaneous Radiofrequency Ablation of the Liver Under Opioid Analgesia. American Journal of Roentgenology 2010;194:799-808. [DOI: 10.2214/ajr.09.3044] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
97 Lencioni R, Crocetti L. Radiofrequency Ablation of Liver Cancer. Techniques in Vascular and Interventional Radiology 2007;10:38-46. [DOI: 10.1053/j.tvir.2007.08.006] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
98 Rosenberg C, Hoffmann C, Mensel B, Puls R, Hosten N. Laserablation: Brauchen wir sie noch? Radiologe 2012;52:15-21. [DOI: 10.1007/s00117-011-2207-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
99 Lee JY, Kim Y, Rhim H, Lim HK, Choi D, Lee WJ. Pattern and Chronological Change of Iodized Oil Retention in Radiofrequency Ablation-Induced Vascular Injury Area: Differentiation From Iodized Oil Retention in Recurrent Hepatocellular Carcinoma on Computed Tomography. Journal of Computer Assisted Tomography 2010;34:354-61. [DOI: 10.1097/rct.0b013e3181cbf43a] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Huang L, Dodd GD, Lanctot AC. Radiofrequency Ablation of the Liver. Academic Radiology 2012;19:1018-22. [DOI: 10.1016/j.acra.2012.04.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
101 Gillams AR. Should hepatocellular carcinoma be ablated or resected? Nat Clin Pract Gastroenterol Hepatol 2007;4:586-7. [PMID: 17925802 DOI: 10.1038/ncpgasthep0962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
102 Pillai K, Akhter J, Chua TC, Shehata M, Alzahrani N, Al-Alem I, Morris DL. Heat sink effect on tumor ablation characteristics as observed in monopolar radiofrequency, bipolar radiofrequency, and microwave, using ex vivo calf liver model. Medicine (Baltimore). 2015;94:e580. [PMID: 25738477 DOI: 10.1097/md.0000000000000580] [Cited by in Crossref: 94] [Cited by in F6Publishing: 41] [Article Influence: 13.4] [Reference Citation Analysis]
103 Livraghi T. Single HCC smaller than 2 cm: surgery or ablation: interventional oncologist’s perspective. J Hepatobiliary Pancreat Sci. 2010;17:425-429. [PMID: 19890600 DOI: 10.1007/s00534-009-0244-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
104 Moribata K, Tamai H, Shingaki N, Mori Y, Shiraki T, Enomoto S, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Ichinose M. Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation. World J Hepatol 2012; 4(12): 374-381 [DOI: 10.4254/wjh.v4.i12.374] [Reference Citation Analysis]
105 Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver. Invest Radiol. 2009;44:800-807. [PMID: 19838119 DOI: 10.1097/rli.0b013e3181bc271d] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
106 Li YC, Chen PH, Yeh JH, Hsiao P, Lo GH, Tan T, Cheng PN, Lin HY, Chen YS, Hsieh KC, Hsieh PM, Lin CW. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis. BMC Gastroenterol 2021;21:418. [PMID: 34749663 DOI: 10.1186/s12876-021-01995-z] [Reference Citation Analysis]
107 Zhang ZH, Kuang XC, Yang H, Peng JB, Qin XX, Zhao GZ. Pathological changes and cell apoptosis in rabbit VX2 liver tumors after radiofrequency ablation. Shijie Huaren Xiaohua Zazhi 2013; 21(17): 1602-1606 [DOI: 10.11569/wcjd.v21.i17.1602] [Reference Citation Analysis]
108 Yun WK, Choi MS, Choi D, Rhim HC, Joh JW, Kim KH, Jang TH, Lee JH, Koh KC, Paik SW, Yoo BC. Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation. Hepatol Int 2011;5:722-9. [PMID: 21484104 DOI: 10.1007/s12072-010-9237-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
109 Kuehl H, Stattaus J, Hertel S, Hunold P, Kaiser G, Bockisch A, Forsting M. Mid-term outcome of positron emission tomography/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumours--a single-centre experience. Clin Oncol (R Coll Radiol). 2008;20:234-240. [PMID: 18155453 DOI: 10.1016/j.clon.2007.11.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
110 Lee DH, Lee JM, Lee JY, Kim SH, Han JK, Choi BI. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis. Cardiovasc Intervent Radiol 2014;37:705-15. [PMID: 23912493 DOI: 10.1007/s00270-013-0708-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
111 Clasen S, Kettenbach J, Kosan B, Aebert H, Schernthaner M, Kröber S, Bömches A, Claussen CD, Pereira PL. Delayed Development of Pneumothorax After Pulmonary Radiofrequency Ablation. Cardiovasc Intervent Radiol 2009;32:484-90. [DOI: 10.1007/s00270-008-9489-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
112 Cha J, Choi D, Lee MW, Rhim H, Kim Y, Lim HK, Yoon JH, Park CK. Radiofrequency Ablation Zones in Ex Vivo Bovine and In Vivo Porcine Livers: Comparison of the Use of Internally Cooled Electrodes and Internally Cooled Wet Electrodes. Cardiovasc Intervent Radiol 2009;32:1235-40. [DOI: 10.1007/s00270-009-9600-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
113 Sugino Y, Yamakado K, Yamanaka T, Fujimori M, Nakatsuka A, Takaki H, Takei Y, Sakuma H, Isaji S. Role of curative treatment in patients with intermediate-stage hepatocellular carcinoma. Jpn J Radiol 2017;35:254-61. [PMID: 28357723 DOI: 10.1007/s11604-017-0628-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
114 Kim DK, Han K, Won JY, Kim GM, Kwon JH, Kim MD. Percutaneous cryoablation in early stage hepatocellular carcinoma: analysis of local tumor progression factors. Diagn Interv Radiol 2020;26:111-7. [PMID: 32071029 DOI: 10.5152/dir.2019.19246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
115 Ray CE Jr, Battaglia C, Libby AM, Prochazka A, Xu S, Funaki B. Interventional radiologic treatment of hepatocellular carcinoma-a cost analysis from the payer perspective. J Vasc Interv Radiol. 2012;23:306-314. [PMID: 22277271 DOI: 10.1016/j.jvir.2011.11.016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
116 Tombesi P, Vece FD, Sartori S. Resection vs thermal ablation of small hepatocellular carcinoma: What's the first choice? World J Radiol 2013; 5(1): 1-4 [PMID: 23493926 DOI: 10.4329/wjr.v5.i1.1] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
117 Au JS, Frenette CT. Management of Hepatocellular Carcinoma: Current Status and Future Directions. Gut Liver. 2015;9:437-448. [PMID: 26087860 DOI: 10.5009/gnl15022] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
118 Lin SM. Local ablation for hepatocellular carcinoma in taiwan. Liver Cancer 2013;2:73-83. [PMID: 24159599 DOI: 10.1159/000343843] [Cited by in Crossref: 26] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
119 Seo JY, Kim W, Kwon JH, Jin EH, Yu SJ, Kim HY, Jung YJ, Kim D, Kim YJ, Yoon JH. Noninvasive fibrosis indices predict intrahepatic distant recurrence of hepatitis B-related hepatocellular carcinoma following radiofrequency ablation. Liver Int. 2013;33:884-893. [PMID: 23461618 DOI: 10.1111/liv.12132] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
120 D'Avola D, Granito A, de la Torre-Aláez M, Piscaglia F. The importance of liver functional reserve in the non-surgical treatment of Hepatocellular Carcinoma. J Hepatol 2021:S0168-8278(21)02185-1. [PMID: 34793869 DOI: 10.1016/j.jhep.2021.11.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 Adam R, Bhangui P, Vibert E, Azoulay D, Pelletier G, Duclos-Vallée JC, Samuel D, Guettier C, Castaing D. Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy? Ann Surg 2012;256:883-91. [PMID: 23108125 DOI: 10.1097/SLA.0b013e318273bad0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
122 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 2018;69:182-236. [PMID: 29628281 DOI: 10.1016/j.jhep.2018.03.019] [Cited by in Crossref: 2122] [Cited by in F6Publishing: 1974] [Article Influence: 530.5] [Reference Citation Analysis]
123 Liu C, He J, Li T, Hong D, Su H, Shao H. Evaluation of the efficacy and postoperative outcomes of hydrodissection-assisted microwave ablation for subcapsular hepatocellular carcinoma and colorectal liver metastases. Abdom Radiol (NY) 2021;46:2161-72. [PMID: 33108496 DOI: 10.1007/s00261-020-02830-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Chang NK, Shin SS, Kim JW, Kim HJ, Jeong YY, Heo SH, Kim JK, Kang HK. Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization. Korean J Radiol 2012;13 Suppl 1:S104-11. [PMID: 22563280 DOI: 10.3348/kjr.2012.13.S1.S104] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
125 Lee DH, Lee JM, Lee JY, Kim SH, Yoon JH, Kim YJ, Han JK, Choi BI. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology. 2014;270:900-909. [PMID: 24475823 DOI: 10.1148/radiol.13130940] [Cited by in Crossref: 155] [Cited by in F6Publishing: 152] [Article Influence: 17.2] [Reference Citation Analysis]
126 Tan Y, Jiang J, Wang Q, Guo S, Ma K, Bie P. Radiofrequency ablation using a multiple-electrode switching system for hepatocellular carcinoma within the Milan criteria: long-term results. International Journal of Hyperthermia 2018;34:298-305. [DOI: 10.1080/02656736.2017.1330495] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
127 Thabet A, Kalva S, Gervais DA. Percutaneous image-guided therapy of intra-abdominal malignancy: imaging evaluation of treatment response. Abdom Imaging 2009;34:593-609. [DOI: 10.1007/s00261-008-9448-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
128 Kim PN, Choi D, Rhim H, Rha SE, Hong HP, Lee J, Choi JI, Kim JW, Seo JW, Lee EJ, Lim HK. Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility. J Vasc Interv Radiol 2012;23:627-34. [PMID: 22387030 DOI: 10.1016/j.jvir.2011.12.026] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
129 Korean Liver Cancer Study Group and National Cancer Center, Korea. [Practice guidelines for management of hepatocellular carcinoma 2009]. Korean J Hepatol. 2009;15:391-423. [PMID: 19783891 DOI: 10.3350/kjhep.2009.15.3.391] [Cited by in Crossref: 182] [Cited by in F6Publishing: 183] [Article Influence: 15.2] [Reference Citation Analysis]
130 Lencioni R, Crocetti L, Pina MCD, Cioni D. Percutaneous image-guided radiofrequency ablation of liver tumors. Abdom Imaging 2009;34:547-56. [DOI: 10.1007/s00261-008-9479-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
131 Massarweh NN, Park JO, Yeung RS, Flum DR. Comparative assessment of the safety and effectiveness of radiofrequency ablation among elderly medicare beneficiaries with hepatocellular carcinoma. Ann Surg Oncol 2012;19:1058-65. [PMID: 21947695 DOI: 10.1245/s10434-011-2067-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
132 Kim Y, Rhim H, Lim HK, Choi D, Lee WJ, Kim SH. Hepatic Infarction after Radiofrequency Ablation of Hepatocellular Carcinoma with an Internally Cooled Electrode. Journal of Vascular and Interventional Radiology 2007;18:1126-33. [DOI: 10.1016/j.jvir.2007.06.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
133 Liu J, Qian LX. Therapeutic efficacy comparison of radiofrequency ablation in hepatocellular carcinoma and metastatic liver cancer. Exp Ther Med 2014;7:897-900. [PMID: 24669247 DOI: 10.3892/etm.2014.1505] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
134 Seror O, N'Kontchou G, Ibraheem M, Ajavon Y, Barrucand C, Ganne N, Coderc E, Trinchet JC, Beaugrand M, Sellier N. Large (& gt; or=5.0-cm) HCCs: multipolar RF ablation with three internally cooled bipolar electrodes--initial experience in 26 patients. Radiology. 2008;248:288-296. [PMID: 18483229 DOI: 10.1148/radiol.2481071101] [Cited by in Crossref: 92] [Cited by in F6Publishing: 80] [Article Influence: 6.6] [Reference Citation Analysis]
135 Peng ZW, Zhang YJ, Chen MS, Lin XJ, Liang HH, Shi M. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results. Eur J Surg Oncol. 2010;36:1054-1060. [PMID: 20846819 DOI: 10.1016/j.ejso.2010.08.133] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 3.1] [Reference Citation Analysis]
136 Cheng YT, Jeng WJ, Lin CC, Chen WT, Sheen IS, Lin CY, Lin SM. Percutaneous radiofrequency ablation of tumor feeding artery before target tumor ablation may reduce local tumor progression in hepatocellular carcinoma. Biomed J 2016;39:400-6. [PMID: 28043419 DOI: 10.1016/j.bj.2016.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
137 Rhim H, Kim Y, Choi D, Lim HK, Park K. Percutaneous radiofrequency ablation of hepatocellular carcinoma: analysis of 80 patients treated with two consecutive sessions. Eur Radiol 2008;18:1442-8. [DOI: 10.1007/s00330-008-0902-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
138 Gervais DA, Arellano RS. Percutaneous tumor ablation for hepatocellular carcinoma. AJR Am J Roentgenol. 2011;197:789-794. [PMID: 21940565 DOI: 10.2214/ajr.11.7656] [Cited by in Crossref: 46] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
139 Kao WY, Chiou YY, Hung HH, Su CW, Chou YH, Wu JC, Huo TI, Huang YH, Wu WC, Lin HC. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy. Clin Radiol. 2012;67:429-436. [PMID: 22153231 DOI: 10.1016/j.crad.2011.10.009] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
140 Rhim H, Lim HK, Choi D. Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg 2010; 2(4): 128-136 [PMID: 21160861 DOI: 10.4240/wjgs.v2.i4.128] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
141 Matkowskyj KA, Bai H, Liao J, Zhang W, Li H, Rao S, Omary R, Yang GY. Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions. Hum Pathol 2014;45:834-43. [PMID: 24656094 DOI: 10.1016/j.humpath.2013.12.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
142 Peng ZW, Lin XJ, Zhang YJ, Liang HH, Guo RP, Shi M, Chen MS. Radiofrequency ablation vs hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study. Radiology. 2012;262:1022-1033. [PMID: 22357902 DOI: 10.1148/radiol.11110817] [Cited by in Crossref: 141] [Cited by in F6Publishing: 130] [Article Influence: 14.1] [Reference Citation Analysis]
143 Elalfy H, Besheer T, Arafa MM, El-Hussiny MA, El Latif MA, Alsayed SAM. Caspase-Cleaved Cytokeratin 18 Fragment M30 as a Potential Biomarker of Macrovascular Invasion in Hepatocellular Carcinoma. J Gastrointest Cancer 2018;49:260-7. [PMID: 28361205 DOI: 10.1007/s12029-017-9937-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
144 Clasen S, Rempp H, Boss A, Schmidt D, Fritz J, Schraml C, Schick F, Claussen CD, Pereira PL. MR-guided radiofrequency ablation of hepatocellular carcinoma: long-term effectiveness. J Vasc Interv Radiol 2011;22:762-70. [PMID: 21530311 DOI: 10.1016/j.jvir.2011.03.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
145 Kang TW, Rhim H, Song KD, Lee MW, Cha DI, Ha SY, Ahn JH. Radiofrequency Ablation of Hepatocellular Carcinoma with a "Nodule-in-Nodule" Appearance: Long-Term Follow-up and Clinical Implications. Cardiovasc Intervent Radiol 2017;40:401-9. [PMID: 27933377 DOI: 10.1007/s00270-016-1525-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
146 Wei Y, Yi Y, Tao C, Ye W, Zhao W. Impact of antiviral therapy with nucleos(t)ide analog on survival of patients with HBV-related small hepatocellular carcinomas. Cancer Manag Res 2019;11:8475-86. [PMID: 31572002 DOI: 10.2147/CMAR.S201744] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
147 Padma S, Martinie JB, Iannitti DA. Liver tumor ablation: Percutaneous and open approaches. J Surg Oncol. 2009;100:619-634. [PMID: 20017157 DOI: 10.1002/jso.21364] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 5.7] [Reference Citation Analysis]
148 Vilgrain V. Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: hepatocellular carcinoma: imaging in assessing treatment efficacy. J Hepatobiliary Pancreat Sci. 2010;17:374-379. [PMID: 19924373 DOI: 10.1007/s00534-009-0230-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
149 Tseng PL, Wang JH, Tung HD, Hung CH, Kee KM, Chen CH, Chang KC, Lee CM, Changchien CS, Chen PF. Optimal treatment increased survival of hepatocellular carcinoma patients detected with community-based screening. J Gastroenterol Hepatol. 2010;25:1426-1434. [PMID: 20659234 DOI: 10.1111/j.1440-1746.2010.06285.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
150 Liu W, Zheng Y, He W, Zou R, Qiu J, Shen J, Yang Z, Zhang Y, Wang C, Wang Y, Zuo D, Li B, Yuan Y. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis. Aliment Pharmacol Ther 2018;48:671-81. [PMID: 30063081 DOI: 10.1111/apt.14929] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 8.5] [Reference Citation Analysis]
151 Zhang F, Wu G, Sun H, Ding J, Xia F, Li X, Ma K, Wang S, Bie P. Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: a single centre with 13 years experience. Int J Hyperthermia 2014;30:471-9. [PMID: 25314335 DOI: 10.3109/02656736.2014.961042] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
152 Thomasset SC, Dennison AR, Garcea G. Ablation for recurrent hepatocellular carcinoma: a systematic review of clinical efficacy and prognostic factors. World J Surg. 2015;39:1150-1160. [PMID: 25634340 DOI: 10.1007/s00268-015-2956-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
153 Hu H, Chi JC, Liu R, Zhai B. Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes. Int J Hyperthermia 2021;38:191-201. [PMID: 33682598 DOI: 10.1080/02656736.2019.1706766] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Crocetti L, Lencioni R. Thermal ablation of hepatocellular carcinoma. Cancer Imaging 2008;8:19-26. [PMID: 18331969 DOI: 10.1102/1470-7330.2008.0004] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
155 Cho JY, Choi MS, Lee GS, Sohn W, Ahn J, Sinn DH, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW. Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma. Clin Mol Hepatol 2016;22:477-86. [PMID: 28081587 DOI: 10.3350/cmh.2016.0048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
156 Lepetit-coiffé M, Laumonier H, Seror O, Quesson B, Sesay M, Moonen CTW, Grenier N, Trillaud H. Real-time monitoring of radiofrequency ablation of liver tumors using thermal-dose calculation by MR temperature imaging: initial results in nine patients, including follow-up. Eur Radiol 2010;20:193-201. [DOI: 10.1007/s00330-009-1532-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
157 Ju JX, Zeng QJ, Xu EJ, He XQ, Tan L, Huang QN, Li K, Zheng RQ. Intraprocedural contrast-enhanced ultrasound-CT/MR fusion imaging assessment in HCC thermal ablation to reduce local tumor progression: compared with routine contrast-enhanced ultrasound. Int J Hyperthermia 2019;36:785-93. [PMID: 31431086 DOI: 10.1080/02656736.2019.1640899] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
158 Rhim H, Lee MH, Kim Y, Choi D, Lee WJ, Lim HK. Planning Sonography to Assess the Feasibility of Percutaneous Radiofrequency Ablation of Hepatocellular Carcinomas. American Journal of Roentgenology 2008;190:1324-30. [DOI: 10.2214/ajr.07.2970] [Cited by in Crossref: 72] [Cited by in F6Publishing: 23] [Article Influence: 5.1] [Reference Citation Analysis]
159 Kim YS, Rhim H, Choi D, Lim HK. Does artificial ascites induce the heat-sink phenomenon during percutaneous radiofrequency ablation of the hepatic subcapsular area?: an in vivo experimental study using a rabbit model. Korean J Radiol 2009;10:43-50. [PMID: 19182502 DOI: 10.3348/kjr.2009.10.1.43] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
160 Wong KM, Yeh ML, Chuang SC, Wang LY, Lin ZY, Chen SC, Tsai JF, Wang SN, Kuo KK, Dai CY, Yu ML, Lee KT, Chuang WL. Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinoma. Indian J Gastroenterol 2013;32:253-7. [PMID: 22932964 DOI: 10.1007/s12664-012-0225-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
161 Paulet E, Aubé C, Pessaux P, Lebigot J, Lhermitte E, Oberti F, Ponthieux A, Calès P, Ridereau-Zins C, Pereira PL. Factors limiting complete tumor ablation by radiofrequency ablation. Cardiovasc Intervent Radiol 2008;31:107-15. [PMID: 17968620 DOI: 10.1007/s00270-007-9208-1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
162 Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm]. Korean J Hepatol. 2009;15:474-485. [PMID: 20037266 DOI: 10.3350/kjhep.2009.15.4.474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
163 Ma S, Ding M, Li J, Wang T, Qi X, Shi Y, Ming Y, Chi J, Wang Z, Tang X, Cui D, Zhang Y, Zhai B. Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors. J Cancer Res Clin Oncol 2017;143:131-42. [DOI: 10.1007/s00432-016-2266-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
164 Wu WC, Chiou YY, Hung HH, Kao WY, Chou YH, Su CW, Wu JC, Huo TI, Huang YH, Lee KC. Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation. J Clin Gastroenterol. 2012;46:789-795. [PMID: 22941428 DOI: 10.1097/mcg.0b013e31825ceeb5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
165 Li X, Zhang X, Li Z, Xie C, Qin S, Yan M, Ke Q, Jin X, Lin T, Zhou M, Liang W, Qi Z, Geng Z, Quan X. Two-Trait Predictor of Venous Invasion on Contrast-Enhanced CT as a Preoperative Predictor of Outcomes for Early-Stage Hepatocellular Carcinoma After Hepatectomy. Front Oncol 2021;11:688087. [PMID: 34540664 DOI: 10.3389/fonc.2021.688087] [Reference Citation Analysis]
166 Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, Paik SW, Koh KC, Lee JH, Choi MS, Gwak GY, Yoo BC. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol. 2013;58:89-97. [PMID: 23023009 DOI: 10.1016/j.jhep.2012.09.020] [Cited by in Crossref: 209] [Cited by in F6Publishing: 193] [Article Influence: 20.9] [Reference Citation Analysis]
167 Liu B, Long J, Wang W, Huang T, Xie X, Chen S, Huang G, Jiang C, Ye J, Long H, Xie X, Kuang M. Predictive factors of treatment outcomes after percutaneous ablation of hepatocellular carcinoma in the caudate lobe: a retrospective study. BMC Cancer 2019;19:699. [PMID: 31311502 DOI: 10.1186/s12885-019-5881-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
168 Rhim H, Lim HK, Kim YS, Choi D, Lee WJ. Radiofrequency ablation of hepatic tumors: lessons learned from 3000 procedures. J Gastroenterol Hepatol. 2008;23:1492-1500. [PMID: 18713294 DOI: 10.1111/j.1440-1746.2008.05550.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
169 Pugalenthi A, Cutter CS, Fong Y. Current treatment for small (< 5 cm) hepatocellular carcinoma: evolving roles for ablation and resection. Adv Surg 2014;48:97-114. [PMID: 25293610 DOI: 10.1016/j.yasu.2014.05.012] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
170 Mori Y, Tamai H, Shingaki N, Moribata K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Terada M, Ichinose M. Signal intensity of small hepatocellular carcinoma on apparent diffusion coefficient mapping and outcome after radiofrequency ablation: ADC mapping and outcome after RFA. Hepatol Res 2015;45:75-87. [DOI: 10.1111/hepr.12311] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
171 Piñero F, Tanno M, Aballay Soteras G, Tisi Baña M, Dirchwolf M, Fassio E, Ruf A, Mengarelli S, Borzi S, Fernández N, Ridruejo E, Descalzi V, Anders M, Mazzolini G, Reggiardo V, Marciano S, Perazzo F, Spina JC, McCormack L, Maraschio M, Lagues C, Gadano A, Villamil F, Silva M, Cairo F, Ameigeiras B; Argentinean Association for the Study of Liver Diseases (A.A.E.E.H). Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma. Ann Hepatol 2020;19:546-69. [PMID: 32593747 DOI: 10.1016/j.aohep.2020.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
172 Cheng JW, Lv Y. New progress of non-surgical treatments for hepatocellular carcinoma. Med Oncol 2013;30:381. [PMID: 23292867 DOI: 10.1007/s12032-012-0381-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
173 Ding M, Ma S, Tang X, Wang T, Qi X, Chi J, Wang Z, Cui D, Shi Y, Zhang Y, Li P, Zhai B. Oliguric acute kidney injury after microwave ablation of large liver tumors: incidence and preventive measures. Int J Hyperthermia 2019;35:141-9. [PMID: 30204038 DOI: 10.1080/02656736.2018.1487589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
174 Park BK, Morrison PR, Tatli S, Govindarajulu U, Tuncali K, Judy P, Shyn PB, Silverman SG. Estimated effective dose of CT-guided percutaneous cryoablation of liver tumors. Eur J Radiol 2012;81:1702-6. [PMID: 21645981 DOI: 10.1016/j.ejrad.2011.04.067] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
175 Kang TW, Rhim H, Lee MW, Kim Y, Choi D, Lee WJ, Lim HK. Radiofrequency Ablation for Hepatocellular Carcinoma Abutting the Diaphragm: Comparison of Effects of Thermal Protection and Therapeutic Efficacy. American Journal of Roentgenology 2011;196:907-13. [DOI: 10.2214/ajr.10.4584] [Cited by in Crossref: 46] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
176 Rim CH, Lee HY, Kim JS, Kim H. Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile? Int J Radiat Biol 2021;97:111-9. [PMID: 33253598 DOI: 10.1080/09553002.2021.1857453] [Reference Citation Analysis]
177 Volk ML, Marrero JA. Early detection of liver cancer: diagnosis and management. Curr Gastroenterol Rep. 2008;10:60-66. [PMID: 18417044 DOI: 10.1007/s11894-008-0010-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
178 Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, Garbagnati F, Silini EM, Dionigi P, Calliada F, Quaretti P. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology. 2011;53:136-147. [PMID: 20967759 DOI: 10.1002/hep.23965] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 8.8] [Reference Citation Analysis]
179 Rhim H, Lim HK. Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: the value of artificial ascites. Abdom Imaging. 2009;34:371-380. [PMID: 18463915 DOI: 10.1007/s00261-008-9408-4] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
180 Schembri V, Piron L, Le Roy J, Hermida M, Lonjon J, Escal L, Pierredon MA, Belgour A, Cassinotto C, Guiu B. Percutaneous ablation of obscure hypovascular liver tumours in challenging locations using arterial CT-portography guidance. Diagn Interv Imaging 2020;101:707-13. [PMID: 33012694 DOI: 10.1016/j.diii.2020.09.005] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
181 de Lope CR, Tremosini S, Forner A, Reig M, Bruix J. Management of HCC. Journal of Hepatology 2012;56:S75-87. [DOI: 10.1016/s0168-8278(12)60009-9] [Cited by in Crossref: 363] [Cited by in F6Publishing: 201] [Article Influence: 36.3] [Reference Citation Analysis]
182 Tan L, Chen S, Wei G, Li Y, Liao J, Jin H, Zou Y, Huang M, Peng Z, Guo Y, Peng S, Xu L, Kuang M. Sublethal heat treatment of hepatocellular carcinoma promotes intrahepatic metastasis and stemness in a VEGFR1-dependent manner. Cancer Letters 2019;460:29-40. [DOI: 10.1016/j.canlet.2019.05.041] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
183 Yang DJ, Luo KL, Liu H, Cai B, Tao GQ, Su XF, Hou XJ, Ye F, Li XY, Tian ZQ. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma. Oncotarget 2017;8:2960-70. [PMID: 27936465 DOI: 10.18632/oncotarget.13813] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
184 Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee FT, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why? Radiographics. 2014;34:1344-1362. [PMID: 25208284 DOI: 10.1053/j.tvir.2007.08.005] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 8.9] [Reference Citation Analysis]
185 Nam SY, Rhim H, Kang TW, Lee MW, Kim Y, Choi D, Lee WJ, Park Y, Chang I, Lim HK. Percutaneous Radiofrequency Ablation for Hepatic Tumors Abutting the Diaphragm: Clinical Assessment of the Heat-Sink Effect of Artificial Ascites. American Journal of Roentgenology 2010;194:W227-31. [DOI: 10.2214/ajr.09.2979] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
186 Qi H, Zhang H, Wan C, Xie L, Song Z, Fan W. CT-guided microwave ablation through the lungs for treating liver tumors near the diaphragm. Oncotarget 2017;8:79270-8. [PMID: 29108305 DOI: 10.18632/oncotarget.17422] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
187 Du J, Li HL, Zhai B, Chang S, Li FH. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results. Ultrasound Med Biol 2015;41:2400-11. [PMID: 26055968 DOI: 10.1016/j.ultrasmedbio.2015.05.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
188 Park Y, Choi D, Rhim H, Kim YS, Lee JY, Chang I, Lim HK, Park CK. Central lower attenuating lesion in the ablation zone on immediate follow-up CT after percutaneous radiofrequency ablation for hepatocellular carcinoma: incidence and clinical significance. Eur J Radiol 2010;75:391-6. [PMID: 19467813 DOI: 10.1016/j.ejrad.2009.04.054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
189 Takaki H, Yamakado K, Nakatsuka A, Yamada T, Uraki J, Kashima M, Yamanaka T, Shiraki K, Takei Y, Takeda K. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images. Int J Clin Oncol 2013;18:46-53. [DOI: 10.1007/s10147-011-0340-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
190 Bartolotta TV, Taibbi A, Midiri M, De Maria M. Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound. Abdom Imaging. 2008;33:501-511. [PMID: 17786507 DOI: 10.1007/s00261-007-9294-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
191 Dodd GD, Dodd NA, Lanctot AC, Glueck DA. Effect of Variation of Portal Venous Blood Flow on Radiofrequency and Microwave Ablations in a Blood-perfused Bovine Liver Model. Radiology 2013;267:129-36. [DOI: 10.1148/radiol.12120486] [Cited by in Crossref: 70] [Cited by in F6Publishing: 62] [Article Influence: 7.8] [Reference Citation Analysis]
192 Breen DJ, Lencioni R. Image-guided ablation of primary liver and renal tumours. Nat Rev Clin Oncol. 2015;12:175-186. [PMID: 25601446 DOI: 10.1038/nrclinonc.2014.237] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 5.9] [Reference Citation Analysis]
193 Yamashita S, Aoki T, Inoue Y, Kaneko J, Sakamoto Y, Sugawara Y, Hasegawa K, Kokudo N. Outcome of salvage hepatic resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapy. Surgery 2015;157:463-72. [DOI: 10.1016/j.surg.2014.10.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
194 Gillams A. Tumour ablation: current role in the liver, kidney, lung and bone. Cancer Imaging. 2008;8 Spec No A:S1-S5. [PMID: 18852074 DOI: 10.1102/1470-7330.2008.9001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
195 Thandassery RB, Goenka U, Goenka MK. Role of local ablative therapy for hepatocellular carcinoma. J Clin Exp Hepatol. 2014;4:S104-S111. [PMID: 25755601 DOI: 10.1016/j.jceh.2014.03.046] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 3.3] [Reference Citation Analysis]
196 Cha J, Kim YS, Rhim H, Lim HK, Choi D, Lee MW. Radiofrequency ablation using a new type of internally cooled electrode with an adjustable active tip: an experimental study in ex vivo bovine and in vivo porcine livers. Eur J Radiol 2011;77:516-21. [PMID: 19800188 DOI: 10.1016/j.ejrad.2009.09.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
197 Zhang L, Wang J, Jiang J, Zhang M, Shen J. CTLA-4 Blockade Suppresses Progression of Residual Tumors and Improves Survival After Insufficient Radiofrequency Ablation in a Subcutaneous Murine Hepatoma Model. Cardiovasc Intervent Radiol 2020;43:1353-61. [PMID: 32607616 DOI: 10.1007/s00270-020-02505-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Snoeren N, Huiskens J, Rijken AM, van Hillegersberg R, van Erkel AR, Slooter GD, Klaase JM, van den Tol PM, Ten Kate FJ, Jansen MC, van Gulik TM. Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression. Ann Surg Oncol 2011;18:3702-10. [PMID: 21590455 DOI: 10.1245/s10434-011-1762-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
199 Choi D, Lim HK, Rhim H. Concurrent and subsequent radiofrequency ablation combined with hepatectomy for hepatocellular carcinomas. World J Gastrointest Surg 2010; 2(4): 137-142 [PMID: 21160862 DOI: 10.4240/wjgs.v2.i4.137] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
200 Luo Y, Fu HY, Huang HL, Li HJ, Zhang J, Zhou YJ, Xu B, Wang J. Transcatheter arterial chemoembolization combined with microwave ablation for treatment of early liver cancer: Efficacy and prognostic factors for progression-free survival. Shijie Huaren Xiaohua Zazhi 2019; 27(19): 1201-1208 [DOI: 10.11569/wcjd.v27.i19.1201] [Reference Citation Analysis]
201 Wang H, Lee JC, Cao K, Tang HW, Wang S, Zhang ZY, Wu W, Yan K, Yang W. What is the difference in ablation zone of multi-bipolar radiofrequency ablation between liver cirrhosis and normal liver background? - a prospective clinical study. Int J Hyperthermia 2020;37:1248-59. [PMID: 33164634 DOI: 10.1080/02656736.2020.1838627] [Reference Citation Analysis]
202 Choi JW, Lee JM, Lee DH, Yoon JH, Suh KS, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK. Switching Monopolar Radiofrequency Ablation Using a Separable Cluster Electrode in Patients with Hepatocellular Carcinoma: A Prospective Study. PLoS One 2016;11:e0161980. [PMID: 27575787 DOI: 10.1371/journal.pone.0161980] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
203 Rong G, Bai W, Dong Z, Wang C, Lu Y, Zeng Z, Qu J, Lou M, Wang H, Gao X, Chang X, An L, Li H, Chen Y, Hu KQ, Yang Y. Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria. PLoS One. 2015;10:e0123065. [PMID: 25849963 DOI: 10.1371/journal.pone.0123065] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
204 Ding J, Jing X, Wang Y, Wang F, Wang Y, Du Z. Thermal ablation for hepatocellular carcinoma: a large-scale analysis of long-term outcome and prognostic factors. Clinical Radiology 2016;71:1270-6. [DOI: 10.1016/j.crad.2016.07.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
205 Tan Y, Wang X, Ma K, Zhang L, Li J, Chen P, Zhang B. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study. Int J Hyperthermia 2022;39:190-9. [PMID: 35042449 DOI: 10.1080/02656736.2021.2024279] [Reference Citation Analysis]
206 Liu W, Zou R, Wang C, Qiu J, Shen J, Liao Y, Yang Z, Zhang Y, Wang Y, Yuan Y, Li K, Zuo D, He W, Zheng Y, Li B, Yuan Y. Microwave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysis. Ther Adv Med Oncol 2019;11:1758835919874652. [PMID: 31588210 DOI: 10.1177/1758835919874652] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
207 Jiang L, Liao A, Wen T, Yan L, Li B, Yang J. Living donor liver transplantation or resection for Child-Pugh A hepatocellular carcinoma patients with multiple nodules meeting the Milan criteria. Transpl Int. 2014;27:562-569. [PMID: 24606007 DOI: 10.1111/tri.12297] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
208 Takahashi M, Maruyama H, Shimada T, Kamezaki H, Okabe S, Kanai F, Yoshikawa M, Yokosuka O. Linear enhancement after radio-frequency ablation for hepatocellular carcinoma: is it a sign of recurrence? Ultrasound Med Biol 2012;38:1902-10. [PMID: 23026230 DOI: 10.1016/j.ultrasmedbio.2012.07.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
209 Hocquelet A, Balageas P, Laurent C, Blanc J, Frulio N, Salut C, Cassinotto C, Saric J, Possenti L, Bernard P, Montaudon M, Trillaud H. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients. International Journal of Hyperthermia 2015;31:749-57. [DOI: 10.3109/02656736.2015.1068382] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
210 Cha J, Rhim H, Lee JY, Kim YS, Choi D, Lee MW, Lee WJ, Lim HK. Percutaneous radiofrequency ablation of hepatocellular carcinoma: assessment of safety in patients with ascites. AJR Am J Roentgenol 2009;193:W424-9. [PMID: 19843722 DOI: 10.2214/AJR.08.1836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
211 Seinstra BA, van Delden OM, van Erpecum KJ, van Hillegersberg R, Mali WP, van den Bosch MA. Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today? Insights Imaging. 2010;1:167-181. [PMID: 23100194 DOI: 10.1007/s13244-010-0027-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
212 Kalra N, Kang M, Bhatia A, Duseja AK, Dhiman RK, Arya VK, Rajwanshi A, Chawla YK, Khandelwal N. Role of radiofrequency ablation in unresectable hepatocellular carcinoma: An Indian experience. Indian J Radiol Imaging. 2013;23:139-144. [PMID: 24082478 DOI: 10.4103/0971-3026.116569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
213 Yang W, Yan K, Goldberg SN, Ahmed M, Lee JC, Wu W, Zhang ZY, Wang S, Chen MH. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World J Gastroenterol 2016; 22(10): 2993-3005 [PMID: 26973395 DOI: 10.3748/wjg.v22.i10.2993] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
214 Lee S, Jeong WK, Rhim H. Repeated percutaneous radiofrequency ablation for hepatocellular carcinoma in patients with cirrhosis: assessment of safety based on liver function and portal hypertension parameters. J Vasc Interv Radiol. 2014;25:1573-1579. [PMID: 25108816 DOI: 10.1016/j.jvir.2014.06.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
215 Lahat E, Eshkenazy R, Zendel A, Zakai BB, Maor M, Dreznik Y, Ariche A. Complications after percutaneous ablation of liver tumors: a systematic review. Hepatobiliary Surg Nutr. 2014;3:317-323. [PMID: 25392844 DOI: 10.3978/j.issn.2304-3881.2014.09.07] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
216 Koo JH, Shin JH, Oh YL, Ko EY, Han B. Sonographically Guided Radiofrequency Ablation With and Without a Superficial Saline Injection to Prevent Skin Burns in a Rabbit Model. Journal of Ultrasound in Medicine 2012;31:873-8. [DOI: 10.7863/jum.2012.31.6.873] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
217 Sartori S, Di Vece F, Ermili F, Tombesi P. Laser ablation of liver tumors: An ancillary technique, or an alternative to radiofrequency and microwave? World J Radiol 2017; 9(3): 91-96 [PMID: 28396723 DOI: 10.4329/wjr.v9.i3.91] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 10] [Article Influence: 4.4] [Reference Citation Analysis]
218 Wong J, Lee KF, Yu SC, Lee PS, Cheung YS, Chong CN, Ip PC, Lai PB. Percutaneous radiofrequency ablation versus surgical radiofrequency ablation for malignant liver tumours: the long-term results. HPB (Oxford) 2013;15:595-601. [PMID: 23458320 DOI: 10.1111/hpb.12014] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
219 Izumi N. Recent advances of radiofrequency ablation for early hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26 Suppl 1:115-122. [PMID: 21199522 DOI: 10.1111/j.1440-1746.2010.06543.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
220 Kim SH, Lim HK, Kim MJ, Choi D, Rhim H, Park CK. Radiofrequency ablation of high-grade dysplastic nodules in chronic liver disease: comparison with well-differentiated hepatocellular carcinoma based on long-term results. Eur Radiol 2008;18:814-21. [PMID: 18080127 DOI: 10.1007/s00330-007-0823-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
221 Chinnaratha MA, Sathananthan D, Pateria P, Tse E, Macquillan G, Mosel L, Pathi R, Madigan D, Wigg AJ. High local recurrence of early-stage hepatocellular carcinoma after percutaneous thermal ablation in routine clinical practice. European Journal of Gastroenterology & Hepatology 2015;27:349-54. [DOI: 10.1097/meg.0000000000000270] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
222 Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47:82-89. [PMID: 18008357 DOI: 10.1002/hep.21933] [Cited by in Crossref: 705] [Cited by in F6Publishing: 654] [Article Influence: 50.4] [Reference Citation Analysis]
223 Sangro B, Salem R, Kennedy A, Coldwell D, Wasan H. Radioembolization for hepatocellular carcinoma: a review of the evidence and treatment recommendations. Am J Clin Oncol. 2011;34:422-431. [PMID: 20622645 DOI: 10.1097/coc.0b013e3181df0a50] [Cited by in Crossref: 63] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
224 Howenstein MJ, Sato KT. Complications of radiofrequency ablation of hepatic, pulmonary, and renal neoplasms. Semin Intervent Radiol. 2010;27:285-295. [PMID: 22550368 DOI: 10.1055/s-0030-1261787] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
225 Hermida M, Cassinotto C, Piron L, Aho-Glélé S, Guillot C, Schembri V, Allimant C, Jaber S, Pageaux GP, Assenat E, Guiu B. Multimodal Percutaneous Thermal Ablation of Small Hepatocellular Carcinoma: Predictive Factors of Recurrence and Survival in Western Patients. Cancers (Basel) 2020;12:E313. [PMID: 32013112 DOI: 10.3390/cancers12020313] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
226 Hatzaras I, Bischof DA, Fahy B, Cosgrove D, Pawlik TM. Treatment options and surveillance strategies after therapy for hepatocellular carcinoma. Ann Surg Oncol 2014;21:758-66. [PMID: 24006095 DOI: 10.1245/s10434-013-3254-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]